Literature DB >> 20661227

Tumor-initiating activity and tumor morphology of HNSCC is modulated by interactions between clonal variants within the tumor.

Sarina R Cameron1, Alison L Dahler, Liliana B Endo-Munoz, Ibtissam Jabbar, Gethin P Thomas, Paul J Leo, Kim Poth, Danny Rickwood, Alexander Guminski, Nicholas A Saunders.   

Abstract

Tumor initiation (TI) in xenotransplantation models of head and neck squamous cell carcinoma (HNSCC) is an inefficient process. Poor TI could be due to (1) posttransplant cell loss, (2) a rare sub-population of cancer stem cells or (3) a requirement for specific cellular interactions, which rely on cell number. By tracking GFP-expressing HNSCC cells, we conclude that the posttransplant loss of cancer cells is minimal in the xenotransplant model. Furthermore, an examination of putative cancer stem cell markers (such as CD133, CD44, SP and label retention) in HNSCC cell lines revealed no correlation between marker expression and tumorigenicity. In addition, single-cell clones randomly isolated from HNSCC cell lines and then transplanted into mice were all capable of initiating tumors with efficiencies varying almost 34-fold. As the observed variation in the clones was both more and less tumorigenic than the parental cells, a combination of two clones, at suboptimal cell numbers for TI, was implanted into mice and was found to modulate the tumor-initiating activity, thus indicating that TI is dependent on a 'critical' number of cells and, for the first time, that interactions between clonal variants within tumors can modulate the overall tumor-initiating activity. Put in context with previous literature on tumorigenic activity, we believe that interactions between clonal variants within a tumor as well as (1) stromal interactions, (2) angiogenic activity, (3) immunocompetence and (4) cancer stem cells may all contribute to tumorigenic potential and the propensity for tumor growth and recurrence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661227     DOI: 10.1038/labinvest.2010.131

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

Review 1.  The biology of head and neck cancer stem cells.

Authors:  Zhaocheng Zhang; Manoel Sant'Ana Filho; Jacques E Nör
Journal:  Oral Oncol       Date:  2011-11-08       Impact factor: 5.337

2.  Downregulation of CEACAM6 gene expression in laryngeal squamous cell carcinoma is an effect of DNA hypermethylation and correlates with disease progression.

Authors:  Kinga Bednarek; Magdalena Kostrzewska-Poczekaj; Marcin Szaumkessel; Katarzyna Kiwerska; Julia Paczkowska; Ewa Byzia; Adam Ustaszewski; Joanna Janiszewska; Anna Bartochowska; Reidar Grenman; Malgorzata Wierzbicka; Krzysztof Szyfter; Maciej Giefing; Malgorzata Jarmuz-Szymczak
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

3.  Comparison of cancer stem cell antigen expression by tumor cell lines and by tumor biopsies from dogs with melanoma and osteosarcoma.

Authors:  Amanda M Guth; Mike Deogracias; Steven W Dow
Journal:  Vet Immunol Immunopathol       Date:  2014-07-24       Impact factor: 2.046

4.  Targeted inhibition of CD133+ cells in oral cancer cell lines.

Authors:  M Damek-Poprawa; A Volgina; J Korostoff; T P Sollecito; M S Brose; B W O'Malley; S O Akintoye; J M DiRienzo
Journal:  J Dent Res       Date:  2011-01-10       Impact factor: 6.116

Review 5.  Cancer stem cells in human digestive tract malignancies.

Authors:  Fatemeh B Rassouli; Maryam M Matin; Morvarid Saeinasab
Journal:  Tumour Biol       Date:  2015-10-07

6.  Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis.

Authors:  Sarina Cameron; Lilia Merida de Long; Mehlika Hazar-Rethinam; Eleni Topkas; Liliana Endo-Munoz; Andrew Cumming; Orla Gannon; Alexander Guminski; Nicholas Saunders
Journal:  Mol Cancer       Date:  2012-09-28       Impact factor: 27.401

Review 7.  Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives.

Authors:  Nicholas A Saunders; Fiona Simpson; Erik W Thompson; Michelle M Hill; Liliana Endo-Munoz; Graham Leggatt; Rodney F Minchin; Alexander Guminski
Journal:  EMBO Mol Med       Date:  2012-06-25       Impact factor: 12.137

8.  Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma.

Authors:  R B Erlich; Z Kherrouche; D Rickwood; L Endo-Munoz; S Cameron; A Dahler; M Hazar-Rethinam; L M de Long; K Wooley; A Guminski; N A Saunders
Journal:  Br J Cancer       Date:  2011-11-24       Impact factor: 7.640

9.  Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies.

Authors:  Benny Johnson; Daruka Mahadevan
Journal:  Clin Cancer Drugs       Date:  2015-02

10.  Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones.

Authors:  Rebecca Macklin; Haolu Wang; Dorothy Loo; Sally Martin; Andrew Cumming; Na Cai; Rebecca Lane; Natalia Saenz Ponce; Eleni Topkas; Kerry Inder; Nicholas A Saunders; Liliana Endo-Munoz
Journal:  Oncotarget       Date:  2016-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.